Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$1.16 - $6.41 $563 - $3,115
486 Added 2.69%
18,578 $21,000
Q4 2022

Feb 07, 2023

BUY
$4.78 - $15.01 $3,269 - $10,266
684 Added 3.93%
18,092 $95,000
Q3 2022

Nov 07, 2022

BUY
$10.22 - $23.7 $541 - $1,256
53 Added 0.31%
17,408 $201,000
Q2 2022

Jul 28, 2022

BUY
$4.35 - $15.85 $374 - $1,363
86 Added 0.5%
17,355 $196,000
Q1 2022

May 04, 2022

BUY
$4.55 - $6.41 $341 - $480
75 Added 0.44%
17,269 $83,000
Q4 2021

Feb 04, 2022

SELL
$5.89 - $9.73 $1,001 - $1,654
-170 Reduced 0.98%
17,194 $101,000
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $2,189 - $3,194
323 Added 1.9%
17,364 $148,000
Q2 2021

Aug 02, 2021

BUY
$7.24 - $11.2 $123,376 - $190,859
17,041 New
17,041 $138,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.